Abstract-Hyperglycemia or high blood glucose (sugar) level is a common dangerous complication among patients with Type 1 diabetes mellitus (T1DM). Hyperglycemia can cause serious health problems if left untreated such as heart disease, stroke, vision and nerve problems. Based on the electrocardiographic (ECG) parameters, we have identified hyperglycemic and normoglycemic states in T1DM patients. In this study, a classification unit is introduced with the approach of feed forward multi-layer neural network to detect the presences of hyperglycemic/normoglycemic episodes using ECG parameters as inputs. A practical experiment using the real T1DM patients' data sets collected from Department of Health, Government of Western Australia is studied. Experimental results show that proposed ECG parameters contributed significantly to the good performance of hyperglycemia detections in term of sensitivity, specificity and geometric mean (70.59%, 65.38%, and 67.94%, respectively). From these results, it is proved that hyperglycemic events in T1DM can be detected non-invasively and effectively by using ECG signals and ANN approach.
I. INTRODUCTION
It is well recognized that hyperglycemia is detrimental and one of the risk factors for adverse outcomes in diabetic patients [1] . Persistent hyperglycemia can cause a wide range of chronic complications that affect almost every system in the body and lead to life-threatening conditions, which require immediate medical attention. To detect an increase in blood glucose level, a diabetic patient needs to frequently monitor blood glucose levels by finger prick testing of blood several times a day. This conventional method significantly discourages the patients from periodically checking blood glucose levels. Therefore, there is a strong demand to have a noninvasive technique that helps patients to diagnose the disease easily and painlessly.
New techniques have been employed to develop a minor invasive and/or noninvasive method for blood glucose monitoring, including infrared spectroscopy [2] , fluorescence spectroscopy for skin glucose sensing [3] , tear glucose [4] , etc. However, results from these techniques need checking frequently against direct blood glucose measurements as they cannot replace the direct result of a blood glucose sensor [5] . Although real-time continuous glucose monitoring systems (CGMS) give real-time estimations of glucose levels, there still remain some limitations including time lag and inaccuracy [6] . Due to these limitations, other methods for the detection of abnormal blood glucose levels should be studied.
Among various medical and healthcare information, electrocardiography (ECG) is known to be the best way to measure and diagnose abnormal rhythms of the heart [7] . Several ECG parameters have been investigated to correlate with the prevalence of hyperglycemia. Recently, we have explored significant abnormal changes of ventricular repolarization intervals and certain ECG parameters under hyperglycemia and hypoglycemia conditions that could be good markers to identify hyperglycemia and hypoglycemia in diabetic patients [8] . Reduced heart rate variability has been seen among hyperglycemic patients and our previous study has demonstrated that high blood glucose levels cause significantly lower HRV in subjects with T1DM [9] . Based on these explorations, corresponding ECG parameters could be determined as good markers for classification models to identify hyperglycemic and normoglycemic states in diabetics. However, these findings have not yet been employed to detect hyperglycemia. There are only a few methods to detect hyperglycemia by not using physiological signals, such as in exhaled methyl nitrates [10] and early detection of ongoing β cell death [11] , which are not commonly used.
Artificial neural network (ANN) has been widely applied in many scientific areas during the past few years, and is currently a very active tool in biomedical research. Most applications of ANNs to biomedical are classification problems; those are extensively utilized in pattern recognition to detect diseases or complex medical conditions. Obviously, ANNs can achieve high performance and computation rates, which are vital in biomedical applications. At least three main studies on hypoglycemia detection, which employ ANNs, have achieved excellent performances with different computational intelligent algorithms [12] [13] [14] . Meanwhile, there is no research on hyperglycemia detection using ECG so far and no advanced computational algorithms have been employed for the classification of hyperglycemia.
In this paper, we propose a new non-invasive hyperglycemia detection system, which is based on the approach of ANN and electrocardiographic (ECG) signals in T1DM patients. Section II provides an overview of the method used for non-invasive and continuous detection of hyperglycemia. Section III presents the development and results of an optimized neural network to identify hyperglycemia using ECG parameters. A conclusion for this study is shown in section IV.
II. METHODS

A. Study
In T1DM patients, hyperglycemic state is defined as those with more than 1 glucose event ≥ 150 mg/dl (8.33 mmol/l) [15] . A database was compiled on the adolescent patients with T1DM who volunteered for overnight hypoglycemia and hyperglycemia study from 9pm to 6am at the Princess Margaret Hospital for Children in Perth, Australia. To prevent the interference of hypoglycemic state that may weaken the evaluation of the influence of hyperglycemia in changes of cardiac ventricular intervals, this research only focuses on subjects with normal and high blood glucose levels. Ten type 1 diabetic patients, who mostly had two glycemic states, hyperglycemia (BGL ≥ 8.33 mmol/l) and normoglycemia (3.33 mmol/l < BGL < 8.33 mml/l), are chosen for collecting data. All data were collected with approval of the Women's and Children's Health Service, Department of Health, Government of Western Australia, and with written informed consent.
18 data points from each patient were used corresponding to the 30-minute duration of each blood glucose sampling point. During the study period, ECG signals were continuously recorded by a medical device called Compumedics with the sampling rate of 512 Hz, while actual blood glucose was collected as reference using Yellow Springs Instruments (Fig. 1) .
B. ECG parameters
30-minute segments of ECG signals were taken according to each sampled blood glucose point for collecting ECG parameters. Based on the effect of hyperglycemia on ECG signals in T1DM, there are sixteen ECG parameters involved to detect hyperglycemia. Five ECG intervals including (i) HR, (ii) PR, (iii) QT C , (iv) RT C , (v) T P T EC were obtained from the patient's ECG signals using a program written in LabVIEW [8] . Index of c in the parameters indicates the correction by heart rate for the variables using the Bazett's formula. The other eleven ECG parameters are a selection of time domain and frequency domain measures of HRV which were considered and performed following the Task Force guidelines [16] .
Time HRV analysis was conducted using the Kubios HRV analysis software package (http://kubios.uku.fi/). This software package was used for analyzing the variability of heart beat intervals. It has an easy-to-use graphical interface that shows the HRV waveform and calculates the timedomain, frequency domain, and non-linear dynamics parameters from the raw RR signals. The software computed all required time and frequency domain features.
Independent t-test was applied to these features to estimate the significant difference between hyperglycemia and non-hyperglycemia conditions. Statistical analyses were conducted with IBM SPSS version 19 (SPSS Inc, Chicago, IL, USA). Significance value (p-value) less than 0.05 is considered to be significant. Results are presented as mean ± standard errors.
C. Classification
In this study, the detection of hyperglycemic state (BGL ≥ 8.33 mmol/l) using sixteen ECG variables is based on an advanced neural network algorithm developed from the obtained clinical data. This neural network has a multilayer feed-forward neural network structure with one input layer, one hidden layer and one output layer. Tansig is the hyperbolic tangent sigmoid transfer function used for hidden layer and output layer. To accelerate the convergence of the error back propagation learning method, the ANN is trained by the Levenberg-Marquardt (LM) algorithm. The output layer has one node, which indicates the state of hyper or normo. The overall data set consists of a training set, validation set, and testing set, which are randomly selected with proportions of 35%, 35%, and 30% out of overall data, respectively. The validation set is used as an early stopping method to make sure the ANN does not over-train. The testing set is then used to test the generalization of the neural network. For these, the whole data set, which included both hyperglycemia data part and non-hyperglycemia data part, was used.
To measure the performance of the classification results, sensitivity and specificity are used [17] . The definitions of sensitivity and the specificity are given as follows: 
where TP (True Positive) is the number of hyperglycemic events which are correctly classified as hyperglycemia; FN (False Negative) is the number of hyperglycemic events which are wrongly classified as normoglycemia; TN (True Negative) is the number of normoglycemic events which are correctly classified as normoglycemia; FP (False Positive) is the number of normoglycemic events which are wrongly classified as hyperglycemia. For the comparison of the performances, a geometric mean gm was also used. The geometric mean equals to the square root of the multiplication of sensitivity and specificity. The geometric mean is suitable to indicate performance of a detection system with imbalanced data [18] . In our study, the number of normoglycemia data is about double the number of hyperglycemia data. Moreover, four other training methods were also applied to the neural network model to compare their performances with the proposed one. They are Gradient descent, Gradient descent with momentum, Scaled conjugate gradient, Resilient back propagation, which are called LM, GD, GDX, SCG and RP, respectively. The same condition was kept in initializing all the networks. Same input, training parameters and learning function were adopted during training process for those five learning algorithms.
III. RESULTS AND DISCUSSION
Normalization was used to reduce patient-to-patient variability and to enable group comparison by subtracting the patient's ECG features to his/her min values and then dividing the results by the differences between the maximum and minimum values [19] . The normalized data will be set in the range between 0 and 1.
The responses from 10 T1DM patients, as shown in Table  I , exhibited significant changes during the hyperglycemic state against normoglycemic state. It can be seen that thirteen out of sixteen parameters in hyperglycemia significantly differed from those in normoglycemia, indicating that a rise in blood glucose levels is associated with a drop in QT C , RT C , TpTe C and HRV measures.
The neural networks applying five algorithms, namely LM, SCG, GDX, CGF, and RP used all 16 original ECG parameters as inputs. The number of hidden neurons varied between 3 and 20 neurons until the best classification was reached with the minimum mean square error (MSE). Table  I shows the best results in terms of sensitivity, specificity and geometric mean from testing set with different input and best numbers of hidden nodes.
LM algorithm, 9 hidden nodes produce the best classification in which the training results of 89.47% sensitivity and 83.87% specificity are gained and the testing set leads to 70.59% sensitivity and 65.38% specificity. These testing sensitivity and specificity are considered to be a satisfactory result which meets the requirements of disease diagnosis (sensitivity ≥ 70% and specificity ≥ 50%). The best testing geometric mean of 67.94% by using LM algorithm is also achieved with these sensitivity and specificity. Apart from LM, the sensitivities of the other four algorithms are less than 70%, which are not directed in biomedical application. For future research, we are continuing to develop advanced algorithms and optimization techniques to improve overall accuracy of hyperglycemia detection. The results of this study might require further validation using different ECG feature extraction methods to yield higher performance. Moreover, a strategy of reducing dimension of input size should be carried out to set up a set of interrelated parameters and find important ECG parameters, which significantly contribute to the performance of hyperglycemia detection. This hyperglycemia detection strategy, after further validation, could be a useful non-invasive and painless method for diabetic patients.
IV. CONCLUSION
In this paper, a classification unit using artificial neural network is developed to determine the presence of hyperglycemia episodes based on T1DM patients' ECG parameters. The results of 70.59% sensitivity and 65.58% specificity by using LM algorithm are considered reasonable and meet the requirement for biomedical application. Various training algorithms also have been developed and compared. In general, the proposed ECG classifier using LM algorithm outperforms other algorithms. This result indicates that hyperglycemic events in T1DM can be detected noninvasively and effectively by using ECG signals and ANN approach.
